221 related articles for article (PubMed ID: 23890327)
1. Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species.
Das M; Saudagar P; Sundar S; Dubey VK
FEBS J; 2013 Oct; 280(19):4807-15. PubMed ID: 23890327
[TBL] [Abstract][Full Text] [Related]
2. Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death.
Mishra J; Singh S
Exp Parasitol; 2013 Oct; 135(2):397-406. PubMed ID: 23968687
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani mitochondrial iron superoxide dismutase A is released into the cytosol during miltefosine induced programmed cell death.
Getachew F; Gedamu L
Mol Biochem Parasitol; 2012 May; 183(1):42-51. PubMed ID: 22342963
[TBL] [Abstract][Full Text] [Related]
4. Leishmania donovani chaperonin TCP1γ subunit protects miltefosine induced oxidative damage.
Yadav S; Ali V; Singh Y; Kanojia S; Goyal N
Int J Biol Macromol; 2020 Dec; 165(Pt B):2607-2620. PubMed ID: 33736277
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
6. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
Verma NK; Singh G; Dey CS
Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
[TBL] [Abstract][Full Text] [Related]
7. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca
Pinto-Martinez AK; Rodriguez-Durán J; Serrano-Martin X; Hernandez-Rodriguez V; Benaim G
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061745
[No Abstract] [Full Text] [Related]
9. Perifosine Mechanisms of Action in Leishmania Species.
López-Arencibia A; Martín-Navarro C; Sifaoui I; Reyes-Batlle M; Wagner C; Lorenzo-Morales J; Maciver SK; Piñero JE
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096161
[TBL] [Abstract][Full Text] [Related]
10. Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment.
Das S; Giri S; Sundar S; Shaha C
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061756
[TBL] [Abstract][Full Text] [Related]
11. Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.
Veronica J; Chandrasekaran S; Dayakar A; Devender M; Prajapati VK; Sundar S; Maurya R
FEBS J; 2019 Sep; 286(17):3488-3503. PubMed ID: 31087522
[TBL] [Abstract][Full Text] [Related]
12. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India.
Srivastava S; Mishra J; Gupta AK; Singh A; Shankar P; Singh S
Parasit Vectors; 2017 Jan; 10(1):49. PubMed ID: 28137296
[TBL] [Abstract][Full Text] [Related]
13. Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
Deep DK; Singh R; Bhandari V; Verma A; Sharma V; Wajid S; Sundar S; Ramesh V; Dujardin JC; Salotra P
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005641. PubMed ID: 28575060
[TBL] [Abstract][Full Text] [Related]
14. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
[TBL] [Abstract][Full Text] [Related]
15. Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani.
Kulshrestha A; Sharma V; Singh R; Salotra P
Parasitol Res; 2014 Mar; 113(3):1171-84. PubMed ID: 24449447
[TBL] [Abstract][Full Text] [Related]
16. Novel Agents against Miltefosine-Unresponsive Leishmania donovani.
Das M; Saha G; Saikia AK; Dubey VK
Antimicrob Agents Chemother; 2015 Dec; 59(12):7826-9. PubMed ID: 26392497
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
Singh R; Kumar D; Duncan RC; Nakhasi HL; Salotra P
Int J Antimicrob Agents; 2010 Jul; 36(1):50-7. PubMed ID: 20427152
[TBL] [Abstract][Full Text] [Related]
18. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
19. Genomic Appraisal of the Multifactorial Basis for In Vitro Acquisition of Miltefosine Resistance in Leishmania donovani.
Vacchina P; Norris-Mullins B; Abengózar MA; Viamontes CG; Sarro J; Stephens MT; Pfrender ME; Rivas L; Morales MA
Antimicrob Agents Chemother; 2016 Jul; 60(7):4089-100. PubMed ID: 27114280
[TBL] [Abstract][Full Text] [Related]
20. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
